| The fiscal consequences attributed to changes in morbidity and mortality linked to investments in health care: a government perspective analytic framework MP Connolly, N Kotsopoulos, MJ Postma, A Bhatt Value in health 20 (2), 273-277, 2017 | 45 | 2017 |
| The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earnings. N Kotsopoulos, MP Connolly, E Sobanski, MJ Postma The journal of mental health policy and economics 16 (1), 27-33, 2013 | 32 | 2013 |
| Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework N Kotsopoulos, MP Connolly, V Remy Health economics review 5, 1-8, 2015 | 23 | 2015 |
| Is the gap between micro-and macroeconomic assessments in health care well understood? The case of vaccination and potential remedies N Kotsopoulos, MP Connolly Journal of Market Access & Health Policy 2 (1), 23897, 2014 | 19 | 2014 |
| Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation N Kotsopoulos, MP Connolly, MJ Postma, RCW Hutubessy Vaccine 31 (46), 5430-5434, 2013 | 19 | 2013 |
| Measuring intra-hospital clinic efficiency and productivity: an application to a Greek university general hospital NM Maniadakis, N Kotsopoulos, PE Prezerakos, JN Yfantopoulos University of Piraeus. International Strategic Management Association, 2008 | 19 | 2008 |
| Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework N Kotsopoulos, G Haitsma, MP Connolly, B Standaert Expert review of pharmacoeconomics & outcomes research 20 (6), 603-612, 2020 | 16 | 2020 |
| Modeling the fiscal costs and benefits of alternative treatment strategies in the United Kingdom for chronic hepatitis C MP Connolly, N Kotsopoulos, A Ustianowski Journal of medical economics 21 (1), 19-26, 2018 | 16 | 2018 |
| Assessment of the broader economic consequences of HPV prevention from a government-perspective: A fiscal analytic approach D Setiawan, N Kotsopoulos, JC Wilschut, MJ Postma, MP Connolly Plos one 11 (8), e0160707, 2016 | 15 | 2016 |
| Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release … J van der Schans, N Kotsopoulos, PJ Hoekstra, E Hak, MJ Postma PLoS One 10 (5), e0127237, 2015 | 15 | 2015 |
| Health care services performance measurement: theory, methods and empirical evidence NM Maniadakis, N Kotsopoulos, PE Prezerakos, JN Yfantopoulos University of Piraeus. International Strategic Management Association, 2009 | 14 | 2009 |
| Evaluation of patients' preferences for genital herpes treatment L Scalone, V Watson, M Ryan, N Kotsopoulos, R Patel Sexually transmitted diseases 38 (9), 802-807, 2011 | 13 | 2011 |
| Measuring across hospital efficiency and productivity: the case of second regional health Authority of Attica PE Prezerakos, NM Maniadakis, D Kaitelidou, N Kotsopoulos, ... University of Piraeus. International Strategic Management Association, 2007 | 13 | 2007 |
| Mobile cardiac outpatient telemetry patch vs implantable loop recorder in cryptogenic stroke patients in the US–cost-minimization model G Medic, N Kotsopoulos, MP Connolly, J Lavelle, V Norlock, M Wadhwa, ... Medical Devices: Evidence and Research, 445-458, 2021 | 12 | 2021 |
| Comparing the fiscal consequences of controlled and uncontrolled osteoarthritis pain applying a UK public economic perspective R Martins, N Kotsopoulos, MK Kließ, C Beck, L Abraham, S Large, ... Journal of Health Economics and Outcomes Research 8 (1), 127, 2021 | 10 | 2021 |
| The fiscal consequences of public health investments in disease-modifying therapies for the treatment of multiple sclerosis in Sweden N Kotsopoulos, MP Connolly, T Dort, A Kavaliunas Journal of medical economics 23 (8), 831-837, 2020 | 8 | 2020 |
| Estimating the Fiscal Consequences of National Immunization Programs Using a “Government Perspective” Public Economic Framework MP Connolly, N Kotsopoulos Vaccines 8 (3), 495, 2020 | 7 | 2020 |
| Cost-effectiveness analysis of hypoallergenic milk formulas for the management of cow’s milk protein allergy in the United Kingdom R Martins, MP Connolly, E Minshall Journal of Health Economics and Outcomes Research 8 (2), 14, 2021 | 6 | 2021 |
| Fiscal impact of smoking cessation in Thailand: A government perspective cost-benefit analysis MP Connolly, N Kotsopoulos, P Suthipinijtham, S Rungruanghiranya Asia Pacific Journal of Public Health 30 (4), 342-350, 2018 | 6 | 2018 |
| A comparison of average wages with age-specific wages for assessing indirect productivity losses: analytic simplicity versus analytic precision MP Connolly, C Tashjian, N Kotsopoulos, A Bhatt, MJ Postma The European Journal of Health Economics 18, 697-701, 2017 | 6 | 2017 |
